DRC Begins Using Experimental Ebola Vaccine In Effort To Stem Outbreak In Conflict Zone

Axios: Congo trying to stem Ebola outbreak with experimental vaccine
“The Democratic Republic of the Congo started using an experimental vaccine against the deadly Ebola virus [Wednesday] after identifying it as the virulent Zaire strain. The latest outbreak has spread to a conflict region and is suspected of killing at least 36 people during its first week…” (O’Reilly, 8/9).

Nature: War zone complicates roll-out of Ebola vaccine in latest outbreak
“…[V]iolence perpetuated by more than 100 armed groups fighting over resources and power in those lush, green provinces has escalated this year in advance of the country’s presidential election scheduled for December. ‘The situation is volatile,’ says Ibrahima Socé-Fall, director of the World Health Organization’s (WHO’s) emergency operations in Africa, based in Brazzaville in the neighboring Republic of Congo. Even so, researchers are also gearing up to give people with Ebola experimental antibody and antiviral drugs in addition to the vaccine…” (Maxmen, 8/8).

Additional coverage of the latest DRC Ebola outbreak is available from Al Jazeera, IRIN, Science Speaks, and Xinhua News.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.